United States · FDA National Drug Code directory
Lithium Carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83209-220_2033aaf7-d874-b7af-e063-6294a90ab0cf
- Product NDC
- 83209-220
- Form
- CAPSULE
- Composition / generic term
- Lithium Carbonate
- Labeler
- Boswell Pharmacy Services LLC d/b/a BPS Wholesale
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240821
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CAPSULE in 1 BLISTER PACK (83209-220-06) · 83209-220-06
- 15 CAPSULE in 1 BLISTER PACK (83209-220-15) · 83209-220-15
- 20 CAPSULE in 1 BLISTER PACK (83209-220-20) · 83209-220-20
- 30 CAPSULE in 1 BLISTER PACK (83209-220-30) · 83209-220-30
- 60 CAPSULE in 1 BLISTER PACK (83209-220-60) · 83209-220-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →